Our industry sees debilitating challenges due to the limitations of traditional trial models in terms of responsiveness and efficiency, specifically in regard to fragmentation among the various technologies and vendors utilized to achieve a common goal – a successful clinical trial. There are a lot of moving parts that occur at all stages of a clinical trial where data is being captured across numerous different platforms or cross-functional teams are executing study tasks independently one of another, ultimately hindering study progress and running up additional unwanted costs. By adopting a unified internal platform to manage study activities and data collection, we can overcome these bottlenecks by streamlining operations and providing better control over the interdependent efforts required to conduct a clinical trial smoothly and on-time.
In this fireside chat, Lindus Health and Signos Chief of Staff, Dan Gusz, reflect on the barriers sponsors have faced for years as a result of fragmentation, as well as how their studies can drastically improve when managed within a singular software environment.
Tune in to discover how modern CROs like Lindus Health employ a unified tech stack designed for running clinical studies end-to-end with speed, quality and patient experience in mind.
Lindus Health Rolls Out “All-in-One Infectious Disease CRO” Bespoke to Clinical Trials for Infectious Disease Interventions
We're excited to introduce our latest CRO offering to the infectious disease market segment.